Patents by Inventor Stephen R. Petteway, Jr.

Stephen R. Petteway, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant plasmin for opthalmic indications
    Patent number: 8231869
    Abstract: Methods of using polynucleotides and polypeptides relating to a recombinantly-modified plasmin(ogen) molecule are provided, including methods related to vitrectomy or vitreolysis. The plasmin(ogen) molecule has a single kringel domain N-terminal to the activation site present in the native human plasminogen molecule, and exhibits lysine-binding and significant enzymatic characteristics associated with the native enzyme.
    Type: Grant
    Filed: October 18, 2006
    Date of Patent: July 31, 2012
    Assignee: Grifols Therapeutics Inc.
    Inventors: Philip Scuderi, Jr., Vikram Arora, Jennifer A. Hunt, Valery Novokhatny, Stephen R. Petteway, Jr.
  • RECOMBINANTLY MODIFIED PLASMIN
    Publication number: 20100047228
    Abstract: Methods of using polynucleotides and polypeptides relating to a recombinantly-modified plasmin(ogen) molecule are provided, including methods related to vitrectomy or vitreolysis. The plasmin(ogen) molecule has a single kringel domain N-terminal to the activation site present in the native human plasminogen molecule, and exhibits lysine-binding and significant enzymatic characteristics associated with the native enzyme.
    Type: Application
    Filed: October 18, 2006
    Publication date: February 25, 2010
    Inventors: Philip Scuderi, JR., Vikram Arora, Jennifer A. Hunt, Valery Novokhatny, Stephen R. Petteway, JR.